BioAmber (BIOA) Misses Q2 EPS by 4c
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
BioAmber (NYSE: BIOA) reported Q2 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.85 million.
For earnings history and earnings-related data on BioAmber (BIOA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Yingli Green Energy (YGE) Posts Q3 Loss of $2.80/Share
- Ollie's Bargain Outlet (OLLI) Tops Q3 EPS by 3c, Offers FY Guidance
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!